Please Wait...

Upcoming Webinar: Avoid the Loss of Patient Data by Efficiently Finding Patients Lost to Follow-Up

Join us for our upcoming webinar on April 5th during which Bernard Hall, Project Manager, Bioclinica LTFU, will present and discuss how to minimize the impact of missing patients and their data on a clinical trial.

Minimum standards have been suggested to prevent and handle missing data, with the focus on prevention. To achieve this, proactive planning during protocol development can facilitate patient retention, by including strategies for patient engagement, patient and caregiver education about the intended or expected treatment outcomes and possible side effects, use of new technologies for alternative data collection methods, among others. However, patients will still drop out for a number of reasons, and finding those patients again is usually beyond the sites’ resources. Therefore, a plan to find missing patients should also be included in the protocol, and patient tracking services can assist with this process. Because these services vary in their effectiveness in both finding and then retaining patients, it’s important to evaluate the trial’s needs against the service offering.

By participating in this webinar, you will:

  • Understand the effect that missing data from patients lost to follow-up (LTFU) can have on the success of the clinical trial
  • Know how to proactively plan for patients LTFU in the initial stages of the clinical trial
  • Be able to identify the options available to find patients who are LTFU
  • Understand the patient tracking option that is best for the specific clinical trial

To join us for this webinar and learn more, register here.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @endpts: #FDA revises draft guidance on #raredisease drug R&D https://t.co/KaNVw54MDE by @ZacharyBrennan via @RAPSorg
Bioclinica (8 hours ago)
RT @PrimeVigilance: News and Press Release - Source @EMA_News now available monthly meeting highlights from #Pharmacovigilance #RiskAssessm…
Bioclinica (8 hours ago)
RT @FDA_Drug_Info: New #FDA Draft Guidance for Industry on Rare Diseases – Common Issues in Drug Development: https://t.co/yxaGyMB7hY. http…
Bioclinica (8 hours ago)
Looking to exercise DDDM in clinical trials? Get tips on obtaining, distilling and presenting data in our new white… https://t.co/NkGrS9JnG8
Bioclinica (10 hours ago)
Is your clinical study supply chain management solution increasing the risk of stock out? Ehsan Ramezani gives pers… https://t.co/YCfP3wCvK6
Bioclinica (Yesterday)
Bioclinica's Kate Adamczuk is presenting at #HAI2019 today! Details on this and other scientific findings at HAI… https://t.co/wDQr6ldfcS
Bioclinica (Yesterday)

Latest Blogs:

Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner